Axinn Recognized in Thirteen Categories of 2026 “Best Law Firms” Report

Print
PDF
Email
Share on LinkedIn
Share on X

Awards & Recognitions | 1 min read

November 10, 2025

Best Lawyers® has released its 2026 Best Law Firms® rankings, and Axinn is proud to announce that the firm has been recognized in thirteen categories across national and regional tiers.

Firms included in the 2026 edition of Best Law Firms® are recognized for professional excellence with consistently impressive ratings from clients and peers.

National Rankings

National Tier 1

Antitrust Law
Litigation – Antitrust

National Tier 3

Commercial Litigation

Regional Rankings

Regional Tier 1

Hartford – Litigation – Insurance
Hartford – Litigation – Intellectual Property
Hartford – Litigation – Patent
New York City – Antitrust Law
New York City – Litigation – Antitrust
Washington, D.C. – Antitrust Law
Washington, D.C. – Litigation – Antitrust

Regional Tier 2

Hartford – Commercial Litigation

About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth—always thinking ahead.

To subscribe to our publications, click here.

Featured Insights

View all Insights

November 19, 2025

Informa 34th Annual Advanced EU Brussels Conference

On November 19, Axinn partner Jimmy Attridge will speak on the "Competition Policy in the New Geopolitical Landscape" panel at Informa's Advanced EU Brussels Conference, being held November 18-19.

Speaking Engagement

Antitrust

November 19, 2025

Kisaco Research Pharma and Biotech Patent Litigation Summit 2025

On November 19, Axinn partner Matthew Murphy will speak on the "Understanding IP Exclusivity Rights Considering the Latest Antitrust Landscape" panel at Kisaco Research's Pharma & Biotech Patent Litigation Summit, being held November 18-19 in Philadelphia.

Speaking Engagement

Intellectual Property

November 18, 2025

GCR Live: Women in Antitrust 2025

On November 18, Axinn partner Lisl Dunlop will speak on "The Next Four Years: Merger Control Following U.S. Leadership Changes" at Global Competition Review's Women in Antitrust conference in Washington, DC.

Speaking Engagement

Antitrust

November 12, 2025

ITCTLA Mock Hearing Program 2025

Axinn partners Brian Johnson and Joseph Micallef have been selected to participate as coaches for the International Trade Commission Trial Lawyers Association’s Mock Hearing Program in Washington, DC on November 12. Associates Raymond Braha and Cassie Goodnight have been selected to participate as NEXT Advocates.

Speaking Engagement

Intellectual Property

October 30, 2025

Axinn Advises Boyd Group Services on its Acquisition of Joe Hudson’s Collision Center

Axinn is pleased to announce that it is serving as antitrust counsel to Boyd Group Services Inc. (“Boyd”; TSX: BYD) in its definitive agreement to acquire Joe Hudson’s Collision Center (“JHCC”) from TSG Consumer Partners LP. Valued at approximately $1.3 billion, the transaction adds 258 collision repair locations across 18 U.S. states, expanding Boyd’s footprint and establishing a leading presence in the growing U.S. Southeast region. Closing is anticipated in the fourth quarter of 2025, subject to customary conditions and regulatory requirements.

Deals & Cases

Antitrust

October 29, 2025

Axinn Advises Thermo Fisher Scientific in Strategic Acquisition of Clario Holdings Inc.

Axinn is pleased to announce that it is acting as regulatory counsel to Thermo Fisher Scientific Inc. (“Thermo Fisher”) in its recently announced definitive agreement to acquire Clario Holdings, Inc. (“Clario”), a global leader in clinical-trial endpoint data solutions, from a shareholder group led by Astorg and Nordic Capital, Novo Holdings, and Cinven. The transaction, valued at approximately $9 billion in cash at closing, plus potential additional performance-based payments, underscores Thermo Fisher’s strategy to deepen its digital, data, and artificial intelligence capabilities in clinical research and biopharma services markets. Following the close, Clario will become part of Thermo Fisher’s Laboratory Products & Biopharma Services segment.

Deals & Cases

Antitrust

Featured Insights

© 2025 Axinn, Veltrop & Harkrider LLP. All Rights Reserved

Back to top